Immune cell analysis in 3,646 breast cancer patients reveals clues for future treatment
NCT ID NCT07545434
First seen Apr 25, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study looked at immune cells called TILs and CD8+ T cells in tumor samples from 3,646 women with early-stage breast cancer who had already received chemotherapy after surgery. The goal was to see if the amount and location of these immune cells were linked to how long patients lived or how long they stayed cancer-free. The research did not test a new treatment but aimed to gather knowledge that could help predict outcomes and guide future therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hellenic Cooperative Oncology Group
Athens, 11526, Greece
Conditions
Explore the condition pages connected to this study.